Featured Companies
Advanced Industrial Marketing

Read how the world's largest B2B companies bring focus to the fuzzy front end to improve new product success! Get your FREE book! (First 100 respondents)
Strategy 2 Market

Specializing in new product development strategy, process, portfolio management, organization and market understanding
MindMatters

Learn how to achieve greater success and full visibility into your NPD process with MindMatters unique New Product Development solution. Click here – you’ll like what you see and you’ll get a free coffee mug!
Upcoming Chapter Events
Carolinas Chapter
September 26, 2013
Triangle Area Networking Breakfast
Chicago Chapter
September 27, 2013
Innovation Day with Chicago PDMA
Georgia Chapter
September 26, 2013
10th Annual Summit
Philadelphia Chapter
October 1, 2013
Enhancing Innovation Through Business and University Partnerships
Quick Links
Visions Magazine
Webcast Series
JPIM
Advertise with PDMA
Email PDMA for more information.
Connect with PDMA
  
Feedback & Submissions
Send your feedback, submissions and questions to Kelly Rehan. |
Don't Miss a Second Chance to Save: PIM 13 Early Bird Extended!
Call for Research Participants
Q3 2013 Visions Magazine Sneak Peek
Book Review: The Price of Global Health
Check Out this Video for a Sneak Peek of the September 26 Webcast: Successful Innovations: How Companies are Creatively Meeting the Need for Growth with New Products with Susan Ward, ITECS Innovative Consulting. You Don't Always Get a Second Chance: Register Before September 21 to Take Advantage of PIM 13's Extended Early Bird Rate
Call for Research Participants
Receive a Benchmark Study on Radical Innovation and Skunk Works
Winner of the 2013 PDMA Dissertation Proposal Competition, Nicole Lasky, is conducting an exciting study on radical innovation and skunk works, with the objective to dispel the myths of innovation and demonstrate a radically different process to that of incremental innovation. This is part of a PhD at the University of New South Wales in Sydney, Australia.
We are seeking principal radical innovators (people who are central to the process of innovation) and managers of radical innovation projects. Radical means new to the world of products, as well as new to the firm. It often creates a dramatic change that transforms existing markets or industries, or creates new ones. In return, you will obtain a report on the benchmark for the radical innovation process and skunk works at the end of the study. This will provide practical advice to managers on how to organize radical innovation projects for the highest potential of success.
Learn more here.
PDMA Publications
Q3 2013 Visions Magazine Sneak Peek
The Q3 issue of Visions will hit email inboxes soon. The issue's cover story features this year's PDMA Outstanding Corporate Innovator finalists:
"It has been repeatedly shown that one of the most effective techniques for organizations facing challenges in improving their innovation performance is to learn from proven successful practitioner companies. This type of learning opportunity is rare, but attendees at PIM13 will be fortunate to take advantage of such an opportunity when the 2013 OCI winners present the best and next innovation practices that have contributed to their success. This is a not-to-be-missed
session at PIM 13. Although our past 47 OCI winners represent significant diversity in industry and size, the common bond is a commitment to innovation as a means to achieve corporate success."
Want to read more? Keep an eye on your inbox for the Q3 issue!
We hope you enjoy Q3's issue and welcome your feedback on the content and new digital format. Do you have comments, questions or suggestions to share? Contact Editor-in-Chief Dennis Coyle to let us know what you think!
PDMA Book Review
The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation
This book is not a trivial accounting and light conversation targeted at average consumers wanting to understand why their drugs cost so much and where/how to get them “cheaply,” though some may gain comprehension of the issue. Rather, it is a deep discussion and interpretation of forces driving our global health care markets backed by Schoonveld’s years of practice and personal investment within this domain.
I must admit to a nervous anxiety throughout this read as I learned that those involved in health care (whether as caregivers, payers or providers) are not only under the pressure of decision making for those involved but also with new drug development and implementation, pricing, market access controls and health economics. To that end, the book offers a forthright discussion on sensitive moral and ethical controversies surrounding health care concerns and a direct, sometimes blunt, accounting of realities.
To read the full book review, click here.
|